Metraipolis › archive › dc_3fda214c701a

Overview of approved COVID-19 vaccines in the EU, recommendations for use in Sweden and vaccine uptake over time: Report from the Swedish Medical Products… — Europe PMC PMID:41189699

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41189699
DOI
10.48101/ujms.v130.12937
License (as archived)
solo-consultazione
Archived
2026-11-09T06:58:06.111Z
SHA-256 of the archived text
681e04edf71b89b2d476a57fc06b55ab55c19b5fccedac3510d65541982ba5e7
Stable URL of this page
https://metraipolis.com/documento/dc_3fda214c701a

How to cite

Overview of approved COVID-19 vaccines in the EU, recommendations for use in Sweden and vaccine uptake over time: Report from the Swedish Medical Products… — Europe PMC PMID:41189699 — Europe PMC (en), https://europepmc.org/article/MED/41189699 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3fda214c701a (Metraipolis archive dc_3fda214c701a, sha256 681e04edf71b89b2d476a57fc06b55ab55c19b5fccedac3510d65541982ba5e7)
BibTeX
@misc{dc3fda214c701a,
  title = {Overview of approved COVID-19 vaccines in the EU, recommendations for use in Sweden and vaccine uptake over time: Report from the Swedish Medical Products… — Europe PMC PMID:41189699},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41189699},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3fda214c701a; sha256 681e04edf71b89b2d476a57fc06b55ab55c19b5fccedac3510d65541982ba5e7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41189699. Agents can read the archived copy with the MCP tool read_document.